212 Section V ■ Vascular Access

15. Wong EC, Schreiber S, Criss V, et al. Feasibility of red blood cell

transfusions through small bore central venous catheters in neonates. Pediatr Res. 2001;49:322A.

16. Vegunta RK, Loethen P, Wallace LJ, et al. Differences in the outcome of surgically placed long-term central venous catheters in

neonates: neck vs groin placement. J Pediatr Surg. 2005;40:47.

17. Murai DT. Are femoral Broviac catheters effective and safe? A

prospective comparison of femoral and jugular venous Broviac

catheters in newborn infants. Chest. 2002;121:1527.

18. Benjamin DK, Miller W, Garges H, et al. Bacteremia, central

catheters, and neonates: when to pull the line. Pediatrics.

2001;107:1272.

19. Vasudevan C, McGuire W. Early removal versus expectant management of central venous catheters in neonates with bloodstream

infection. Cochrane Database Syst Rev. 2011;10:CD008436.

20. Ramasethu J. Complications of vascular catheters in the neonatal

intensive care unit. Clin Perinatol. 2008;35:199.

21. Rastogi S, Bhutada A, Sahni R, et al. Spontaneous correction of

the malpositioned percutaneous central venous line in infants.

Pediatr Radiol. 1998;28:694.

22. Doellman D. Prevention, assessment and treatment of central

venous catheter occlusions in neonatal and young pediatric

patients. J Infus Nurs. 2011;34:251.

23. Soylu H, Brandao LR, Lee KS. Efficacy of local instillation of

recombinant tissue plasminogen activator for restoring occluded

central venous catheters in neonates. J Pediatr. 2010;156:197.

24. Monagle P, Chalmers E, Chan A, et al. Antithrombotic therapy

for neonates and children: American College of Chest Physicians

Evidence Based Clinical Practice Guidelines (8th Edition).

Chest. 2008;133:887S.

25. Svoboda P, Barton RP, Barbarash OL, et al. Recombinant urokinase is safe and effective in restoring patency to occluded central

venous access devices: a multiple-center, international trial. Crit

Care Med. 2004;32:1990.

26. Beardsley DS. Venous thromboembolism in the neonatal period.

Semin Perinatol. 2007;31:250.

27. Chiang MC, Chou YH, Chiang CC, et al. Successful removal of

a ruptured silastic percutaneous central venous catheter in a tiny

premature infant. Chang Gung Med J. 2006;29:603.

28. Evans M, Lentsch D. Percutaneously inserted polyurethane central catheters in the NICU: one unit’s experience. Neonatal

Network. 1999;18:37.

29. Nguyen ST, Lund CH, Durand DJ. Thrombolytic therapy for

adhesions of percutaneous central venous catheters to vein intima

associated with Malassezia furfur infection. J Perinatol. 2001;

21:331.


Comments

Search This Blog

Archive

Show more

Popular posts from this blog

TRIPASS XR تري باس

CELEPHI 200 MG, Gélule

ZENOXIA 15 MG, Comprimé

VOXCIB 200 MG, Gélule

Kana Brax Laberax

فومي كايند

بعض الادويه نجد رموز عليها مثل IR ، MR, XR, CR, SR , DS ماذا تعني هذه الرموز

NIFLURIL 700 MG, Suppositoire adulte

Antifongiques مضادات الفطريات

Popular posts from this blog

علاقة البيبي بالفراولة بالالفا فيتو بروتين

التغيرات الخمس التي تحدث للجسم عند المشي

إحصائيات سنة 2020 | تعداد سكَان دول إفريقيا تنازليا :

ما هو الليمونير للأسنان ؟

ACUPAN 20 MG, Solution injectable

CELEPHI 200 MG, Gélule

الام الظهر

VOXCIB 200 MG, Gélule

ميبستان

Popular posts from this blog

TRIPASS XR تري باس

CELEPHI 200 MG, Gélule

Popular posts from this blog

TRIPASS XR تري باس

CELEPHI 200 MG, Gélule

ZENOXIA 15 MG, Comprimé

VOXCIB 200 MG, Gélule

Kana Brax Laberax

فومي كايند

بعض الادويه نجد رموز عليها مثل IR ، MR, XR, CR, SR , DS ماذا تعني هذه الرموز

NIFLURIL 700 MG, Suppositoire adulte

Antifongiques مضادات الفطريات

Popular posts from this blog

Kana Brax Laberax

TRIPASS XR تري باس

PARANTAL 100 MG, Suppositoire بارانتال 100 مجم تحاميل

الكبد الدهني Fatty Liver

الم اسفل الظهر (الحاد) الذي يظهر بشكل مفاجئ bal-agrisi

SEDALGIC 37.5 MG / 325 MG, Comprimé pelliculé [P] سيدالجيك 37.5 مجم / 325 مجم ، قرص مغلف [P]

نمـو الدمـاغ والتطـور العقـلي لـدى الطفـل

CELEPHI 200 MG, Gélule

أخطر أنواع المخدرات فى العالم و الشرق الاوسط

Archive

Show more